• Plk1 Regulation of p31comet in Mitotic Checkpoint Disassembl

  2026-06-06

  This study elucidates how Polo-like kinase 1 (Plk1) modulates the activity of p31comet during the disassembly of mitotic checkpoint complexes (MCC), a critical process for accurate chromosome segregation. By mapping Plk1-dependent phosphorylation of p31comet and detailing its functional consequences, the research advances our understanding of mitotic checkpoint regulation with implications for cell cycle and cancer biology.

• Tioconazole in Antifungal Research: Advanced Protocols and I

  2026-06-05

  Tioconazole stands out as a high-purity antifungal medication, enabling robust experimental workflows for drug development and fungal infection models. This guide translates recent mechanistic discoveries into actionable protocols, troubleshooting strategies, and advanced use-cases for biomedical researchers.

• APEX2's Role in TERT Expression Regulation in Human Stem Cel

  2026-06-05

  This study demonstrates that APEX2, but not its paralog APEX1, is essential for efficient TERT gene expression in human embryonic stem cells. By revealing a link between DNA repair enzymes, repetitive DNA elements, and telomerase regulation, the work advances our understanding of telomere maintenance and potential cancer therapeutics.

• Angiotensin II: Mechanism-Guided Strategies for Vascular Dis

  2026-06-04

  This article provides translational researchers with a mechanistic roadmap for leveraging Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe) in advanced vascular disease models. Bridging mitochondrial NAD+ biology, extracellular matrix turnover, and the pathogenesis of aneurysm, we articulate how APExBIO’s Angiotensin II enables high-fidelity mechanistic studies. Protocol guidance, differentiation from conventional approaches, and future outlooks are delivered for credible, actionable research design.

• HyperScribe T7 High Yield Cy5 RNA Labeling Kit: Workflow Gui

  2026-06-04

  The HyperScribe T7 High Yield Cy5 RNA Labeling Kit delivers customizable, high-yield fluorescent RNA probes for sensitive applications like in situ hybridization and Northern blotting. Its tunable Cy5-UTP incorporation and robust protocol empower researchers to optimize probe performance for demanding workflows.

• Rifampin for Transcription Inhibition: Advanced Workflows &

  2026-06-03

  Rifampin stands out as a benchmark rifamycin antibiotic for probing bacterial transcription, engineering synthetic biology circuits, and modeling resistance. This guide translates the latest research and proven workflows into actionable, high-fidelity protocols for consistent results in transcriptional regulation studies.

• Cyclic Pifithrin-α hydrobromide: Reliable p53 Inhibition in

  2026-06-03

  This article addresses critical workflow challenges in cell viability and apoptosis assays, demonstrating how Cyclic Pifithrin-α hydrobromide (SKU A4477) enables reproducible p53 pathway inhibition. Through scenario-driven Q&A, it provides actionable guidance for biomedical researchers seeking robust, data-backed solutions in cancer and neuroinflammation models.

• Senescence Genes as Biomarkers in Abdominal Aortic Aneurysm

  2026-06-02

  This study applies integrative transcriptomic and machine learning strategies to identify senescence-related genes as noninvasive biomarkers for abdominal aortic aneurysm (AAA). The validation of ETS1 and ITPR3 as diagnostic candidates offers new avenues for early AAA detection and potential therapeutic targeting.

• ETS1 Modulates Mitophagy via SENP2/HSPA8/FUNDC1 in BPD Model

  2026-06-02

  The referenced study identifies ETS1 as a key regulator of mitophagy in bronchopulmonary dysplasia (BPD), acting through the SENP2/HSPA8/FUNDC1 axis to inhibit mitochondrial damage-induced autophagy. These findings offer new mechanistic insight into lung injury and suggest targeted strategies for autophagy pathway modulation in neonatal lung disease.

• SQOR Drives Ferroptosis Resistance in Hypoxic Pancreatic Can

  2026-06-01

  Lin et al. provide a comprehensive multi-omics and deep learning analysis revealing that upregulation of SQOR promotes ferroptosis resistance in hypoxic pancreatic ductal adenocarcinoma (PDAC). Their findings establish SQOR as a pivotal regulator of tumor cell survival under hypoxia and highlight its potential as a therapeutic target.

• HyperScribe T7 High Yield Cy5 RNA Labeling Kit: Advancing Ma

  2026-06-01

  Explore the HyperScribe T7 High Yield Cy5 RNA Labeling Kit's pivotal role in high-sensitivity RNA probe synthesis for efferocytosis and inflammation research. Gain unique insight into how Cy5 RNA labeling empowers cutting-edge studies in macrophage-mediated clearance, bridging innovative methodology with translational impact.

• Tofacitinib (CP-690550): Rewiring Macrophage Immunometabolis

  2026-05-31

  Explore how Tofacitinib (CP-690550) enables translational researchers to target both inflammatory and metabolic dysfunction in rheumatoid arthritis macrophages. This thought-leadership piece uniquely integrates mechanistic insights, actionable protocols, and strategic guidance, advancing beyond standard product literature to empower the next wave of immune modulation research.

• Mitochondrial Apoptosis and Muscle Atrophy in Ovarian Cancer

  2026-05-30

  This study elucidates the distinct roles of mitochondrial-linked apoptosis and necroptosis in skeletal muscle wasting during ovarian cancer progression. Using a metastatic mouse model, the authors show that mitochondrial ROS-driven activation of apoptotic caspases is attenuated by SkQ1, but this does not prevent muscle atrophy, indicating that neither mitochondrial apoptosis nor necroptosis are causally linked to muscle loss in this context.

• HNF4A Hypermethylation Drives EMT in H. pylori-Linked Gastri

  2026-05-29

  This study uncovers how Helicobacter pylori infection leads to gastric cancer by triggering promoter hypermethylation and silencing of the tumor suppressor gene HNF4A, disrupting epithelial polarity and activating EMT signaling. These findings clarify a key epigenetic mechanism in gastric carcinogenesis and open avenues for targeted epigenetic intervention.

• HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L): Technical Use Gu

  2026-05-29

  The HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody addresses the need for sensitive, specific fluorescent detection of rabbit primary antibodies in immunofluorescence, microscopy, and flow cytometry. It should be used where robust signal amplification and low cross-reactivity are critical, but is not suitable for non-rabbit primaries or applications incompatible with sodium azide or glycerol.

15912 records 1/1061 page Next 12345 下5页 Last page